BiotechTube
Home/SFA Therapeutics/Mark Feitelson
MF

Mark Feitelson

Co-Founder & Scientific Advisor

SFA Therapeutics

Therapeutic Areas

Autoimmune DiseasesDermatologyOncology

SFA Therapeutics Pipeline

DrugIndicationPhase
SFA-002Plaque Psoriasis (Mild-to-severe)Phase 2
SFA-009Pancreatic Cancer (combination therapy)Preclinical
SFA-001Liver Cancer (chronic liver disease to hepatocellular carcinoma)Preclinical

Leadership Team at SFA Therapeutics

SO
Shawn O'Brien
Chairman
IC
Ira C. Spector
Co-Founder & Chief Scientific Officer
AA
Alla Arzumanyan
Co-Founder & Chief Development Officer
View full SFA Therapeutics profile